BioCentury | Feb 23, 2019
Tools & Techniques

Modeling now for precision later

...of the health interventions they pay for,” Hill said. Hill said GNS has partnerships with Blue Cross Blue Shield...
...and gaining better market access because of it,” Hill told BioCentury. Companies and Institutions Mentioned Blue Cross Blue Shield...
BioCentury | Jan 11, 2019
Company News

bluebird's five-year pricing model for LentiGlobin could resonate with payers

...success. He named CAR T as another modality that could benefit from a similar approach. Blue Cross Blue Shield...
BioCentury | Jan 9, 2019
Company News

bluebird's five-year pricing model for LentiGlobin could resonate with payers

...success. He named CAR T as another modality that could benefit from a similar approach. Blue Cross Blue Shield...
BioCentury | Nov 5, 2018
Politics & Policy

Patient, consumer groups push back on biologics exclusivity

...Pharmacy (AMCP), America’s Health Insurance Plans (AHIP), American College of Physicians, Association for Accessible Medicines, Blue Cross and Blue Shield Association...
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...inflammatory or neurodegenerative,” CEO William Hagstrom told BioCentury. Octave, which was founded in 2014 with Blue Cross Blue Shield...
...Medical Center, Boston, Mass. BGI Research, Shenzhen, China BlackThorn Therapeutics Inc., South San Francisco, Calif. Blue Cross Blue Shield...
BioCentury | Jun 23, 2018
Strategy

Gawande’s Cheesecake Factory

...2.2 million prescription drug scripts. Amazon provides a high-deductible health plan that is administered by Blue Cross Blue Shield...
...Amazon.com Inc., (NASDAQ:AMZN), Seattle, Wash. Ariadne Labs, Boston, Mass. Berkshire Hathaway Inc. (NYSE:BRK.A), Omaha, Neb. Blue Cross and Blue Shield Association...
BioCentury | May 25, 2018
Product Development

Patients at the core

...Haemophilia Society Bayer AG (Xetra:BAYN) FDA Canadian Agency for Drugs and Technologies in Health (CADTH) Blue Cross and Blue Shield Association...
...Assessment of Social Services (SBU), the Canadian Agency for Drugs and Technologies in Health (CADTH), Blue Cross Blue Shield...
...data now,” he added. Companies and Institutions Mentioned BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), San Rafael, Calif. Blue Cross Blue Shield...
BioCentury | Apr 20, 2018
Company News

Highmark, AstraZeneca in outcomes-based Symbicort contract

...a financial savings." Blue Cross and Blue Shield Association, Chicago, Ill. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pulmonary Sandi Wong Symbicort AstraZeneca plc Blue Cross and Blue Shield Association...
BioCentury | Apr 17, 2018
Company News

Highmark, AstraZeneca in outcomes-based Symbicort contract

...if a positive outcome is not achieved, the company "will realize a financial savings." Sandi Wong Symbicort AstraZeneca plc Blue Cross Blue Shield...
BioCentury | Feb 10, 2018
Politics, Policy & Law

Money in your pocket

...get to the heart of the issue, which is the manufacturer’s price of a medication.” Blue Cross Blue Shield...
...manufacturer rebates.” Unlike drug companies, PCMA did not offer a solution for the cross-subsidization problem. Blue Cross Blue Shield...
...rebate pass-through. Companies and Institutions Mentioned AARP, Washington, D.C. Biotechnology Innovation Organization (BIO), Washington, D.C. Blue Cross Blue Shield...
Items per page:
1 - 10 of 60
BioCentury | Feb 23, 2019
Tools & Techniques

Modeling now for precision later

...of the health interventions they pay for,” Hill said. Hill said GNS has partnerships with Blue Cross Blue Shield...
...and gaining better market access because of it,” Hill told BioCentury. Companies and Institutions Mentioned Blue Cross Blue Shield...
BioCentury | Jan 11, 2019
Company News

bluebird's five-year pricing model for LentiGlobin could resonate with payers

...success. He named CAR T as another modality that could benefit from a similar approach. Blue Cross Blue Shield...
BioCentury | Jan 9, 2019
Company News

bluebird's five-year pricing model for LentiGlobin could resonate with payers

...success. He named CAR T as another modality that could benefit from a similar approach. Blue Cross Blue Shield...
BioCentury | Nov 5, 2018
Politics & Policy

Patient, consumer groups push back on biologics exclusivity

...Pharmacy (AMCP), America’s Health Insurance Plans (AHIP), American College of Physicians, Association for Accessible Medicines, Blue Cross and Blue Shield Association...
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...inflammatory or neurodegenerative,” CEO William Hagstrom told BioCentury. Octave, which was founded in 2014 with Blue Cross Blue Shield...
...Medical Center, Boston, Mass. BGI Research, Shenzhen, China BlackThorn Therapeutics Inc., South San Francisco, Calif. Blue Cross Blue Shield...
BioCentury | Jun 23, 2018
Strategy

Gawande’s Cheesecake Factory

...2.2 million prescription drug scripts. Amazon provides a high-deductible health plan that is administered by Blue Cross Blue Shield...
...Amazon.com Inc., (NASDAQ:AMZN), Seattle, Wash. Ariadne Labs, Boston, Mass. Berkshire Hathaway Inc. (NYSE:BRK.A), Omaha, Neb. Blue Cross and Blue Shield Association...
BioCentury | May 25, 2018
Product Development

Patients at the core

...Haemophilia Society Bayer AG (Xetra:BAYN) FDA Canadian Agency for Drugs and Technologies in Health (CADTH) Blue Cross and Blue Shield Association...
...Assessment of Social Services (SBU), the Canadian Agency for Drugs and Technologies in Health (CADTH), Blue Cross Blue Shield...
...data now,” he added. Companies and Institutions Mentioned BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), San Rafael, Calif. Blue Cross Blue Shield...
BioCentury | Apr 20, 2018
Company News

Highmark, AstraZeneca in outcomes-based Symbicort contract

...a financial savings." Blue Cross and Blue Shield Association, Chicago, Ill. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pulmonary Sandi Wong Symbicort AstraZeneca plc Blue Cross and Blue Shield Association...
BioCentury | Apr 17, 2018
Company News

Highmark, AstraZeneca in outcomes-based Symbicort contract

...if a positive outcome is not achieved, the company "will realize a financial savings." Sandi Wong Symbicort AstraZeneca plc Blue Cross Blue Shield...
BioCentury | Feb 10, 2018
Politics, Policy & Law

Money in your pocket

...get to the heart of the issue, which is the manufacturer’s price of a medication.” Blue Cross Blue Shield...
...manufacturer rebates.” Unlike drug companies, PCMA did not offer a solution for the cross-subsidization problem. Blue Cross Blue Shield...
...rebate pass-through. Companies and Institutions Mentioned AARP, Washington, D.C. Biotechnology Innovation Organization (BIO), Washington, D.C. Blue Cross Blue Shield...
Items per page:
1 - 10 of 60